Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 54 citing articles:

PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation
Luis Eduardo Alves Damasceno, Douglas da Silva Prado, Flávio P. Veras, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 10
Open Access | Times Cited: 182
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Zimei Yang, Qiuhua Zhang, Linghong Yu, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113249-113249
Closed Access | Times Cited: 163
Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology
Snehlata Yadav, Ajay Sharma, Gulzar Ahmad Nayik, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 67
Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches
Qiang Sun, Ting Gong, Maolun Liu, et al.
Phytomedicine (2021) Vol. 94, pp. 153805-153805
Closed Access | Times Cited: 95
Recent advances in cancer chemoprevention with phytochemicals
Yen‐Chun Koh, Chi‐Tang Ho, Min‐Hsiung Pan
Journal of Food and Drug Analysis (2019) Vol. 28, Iss. 1, pp. 14-37
Open Access | Times Cited: 91
Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review
Sajad Fakhri, Seyed Zachariah Moradi, Mohammad Hosein Farzaei, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 276-305
Closed Access | Times Cited: 76
Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α
Yan Chen, Jingyu Zhang, Minqin Zhang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 11
Open Access | Times Cited: 55
Promising Nanomedicines of Shikonin for Cancer Therapy
Chunmei Yan, Qiuxia Li, Qiang Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1195-1218
Open Access | Times Cited: 37
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 6
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway
Chang Bao, Tao Liu, Ling-Bo Qian, et al.
Journal of Cancer (2020) Vol. 12, Iss. 1, pp. 76-88
Open Access | Times Cited: 41
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 23
Pharmacological and analytical aspects of alkannin/shikonin and their derivatives: An update from 2008 to 2022
Kirandeep Kaur, Rashi Sharma, Atamjit Singh, et al.
Chinese Herbal Medicines (2022) Vol. 14, Iss. 4, pp. 511-527
Open Access | Times Cited: 22
Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells
Anqi Wang, Jiayu Liu, Yuhan Yang, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 26
Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
Flávio P. Veras, Gabriel Azevedo Públio, Bruno Marcel Silva de Melo, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111897-111897
Open Access | Times Cited: 19
Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways
József Király, Erzsébet Szabó, Petra Fodor, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6725-6725
Open Access | Times Cited: 9
Deoxyshikonin Inhibits Viability and Glycolysis by Suppressing the Akt/mTOR Pathway in Acute Myeloid Leukemia Cells
Wu Huijuan, Hongmian Zhao, Li Chen
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 25
Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line
Wei Yang, Jianhua Liu, Lin Hou, et al.
Life Sciences (2020) Vol. 265, pp. 118796-118796
Closed Access | Times Cited: 25
Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis
Hongwei Han, Wenxue Sun, Feng Lu, et al.
PeerJ (2021) Vol. 9, pp. e10675-e10675
Open Access | Times Cited: 21
Inhibition of Mitochondrial Biosynthesis Using a “Right‐Side‐Out” Membrane‐Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple‐Negative Breast Cancer
Jianqing Peng, Xiaoxia Hu, Shuangqin Fan, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 18
Closed Access | Times Cited: 15
Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells
Wenjing Ji, Xiaoyan Sun, Yang Gao, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2747-2747
Open Access | Times Cited: 14
β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis
Zhixuan Wu, Haodong Wu, Ziqiong Wang, et al.
Phytomedicine (2023) Vol. 114, pp. 154769-154769
Closed Access | Times Cited: 8
MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells
Giovanni Pratelli, Daniela Carlisi, Diana Di Liberto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11149-11149
Open Access | Times Cited: 8
Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 501-574
Closed Access | Times Cited: 8
Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models
Ran Zhao, Fanxiang Yin, Mangaladoss Fredimoses, et al.
Phytomedicine (2024) Vol. 129, pp. 155612-155612
Open Access | Times Cited: 2
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
Risav Banerjee, Indrajit Maitra, T. Bhattacharya, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104417-104417
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top